Phase 4 Osteoarthritis Trial, Recruiting NCT06557018 Sponsor: Dezhou Hospital Qilu Hospital of Shandong University Condition: Osteoarthritis
Back to Osteoarthritis

Phase 4 Osteoarthritis Trial, Recruiting

NCT06557018
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been rated as generally healthy or having only mild health conditions by your anesthesia team (called ASA grade I or II), can read and understand Chinese, and are able to communicate clearly with your doctors
  • You are planning to have your first total knee replacement surgery on one knee only, under general anesthesia, and have never had previous surgery on that knee
  • You are willing to take part voluntarily, sign a consent form, and take part in all required assessments

Who may not be able to join:

  • You are already using other pain management treatments before your surgery
  • You have nerve or muscle problems in the leg being operated on, or other health conditions that could affect your recovery after surgery
  • You have an allergy, sensitivity, or any medical reason why you cannot take any of the medications being used in this study
  • You have had a heart artery blockage, a stent placed in a blood vessel, a blood clot in a vein, a blood clot in the lungs, a heart attack, or a stroke within the past 6 months
  • You have serious liver or kidney problems, blood clotting disorders, an irregular heartbeat, an active infection, or other conditions that make surgery unsafe
  • You have any neurological (brain or nerve) or psychiatric (mental health) conditions that could affect your pain after surgery or make it difficult to take part in the study assessments (confirm with trial site)
  • You have a history of misusing, abusing, or being dependent on opioid painkillers, other prescription medications, illegal drugs, or alcohol

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Dezhou Hospital Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
25 June 2024
Est. completion
31 August 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The VAS scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov